WALTHAM, Mass.--(BUSINESS WIRE)--Inverness Medical Innovations, Inc. (Amex: IMA) today announced that it has submitted a new binding offer to acquire Biosite Incorporated (Nasdaq: BSTE) via a cash tender offer at $92.50 per share, enhancing the value of its prior proposal by $2.50 per share.
